# Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias

> **NCT04202770** · NA · SUSPENDED · sponsor: **Neurological Associates of West Los Angeles** · enrollment: 300 (estimated)

## Conditions studied

- Refractory Depression
- Anxiety Disorders
- Neurodegenerative Diseases

## Interventions

- **OTHER:** Exosomes

## Key facts

- **NCT ID:** NCT04202770
- **Lead sponsor:** Neurological Associates of West Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-12-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 300 (ESTIMATED)
- **Why stopped:** Pending COVID-19 pandemic; pending status of product development
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202770, "Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04202770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*